Extra Free Paper

Wenjie Hu,Zhenwei Peng,Dongming Li,Shunli,Shen,Baoxian Liu,Manxia Lin,Hong Peng,Shaoqiang Li,Baogang Peng,Xiaoyan Xie,Mingde Lu,Ming Kuang

DOI: https://doi.org/10.1111/1744-1633.12144

2015-01-01

Surgical Practice

Abstract:Aim: To study the clinical and biochemical outcomes of total parathyroidectomy without auto-transplantation versus partial parathyroidectomy in patients suffering from secondary hyperparathyroidism. Methods: 49 patients who had undergone parathyroidectomy (PTX) for the treatment of secondary hyperparathyroidism from 1997 to 2004 in Prince of Wales Hospital, Hong Kong were recruited in the study (40 total PTX vs 8 partial PTX vs 1 total PTX with auto-transplantation). Demographic data, details of renal replacement therapy, results of imaging and biochemical tests, operative details of PTX, details of medications, any recurrence of hyperparathyroidism and any kidney transplantation were included and analyzed. Results: The mode of PTX had no statistically significant relationship with the incidence of postoperative hypocalcemia, lowest calcium level within 30 days of operation, postoperative use of intravenous calcium or oral vitamin D supplements and other operative complications. While patients having total PTX required a higher dosage of oral calcium carbonate supplement upon discharge (mean difference 7300 mg daily, 95% CI from 502 mg to 14098 mg daily, p < 0.05), there was no such difference on the dosage upon 1-year and latest FU. Our study showed no statistically significant difference between the mode of PTX and the recurrence of hyperparathyroidism (7.5% in total PTX vs 33.3% in partial PTX, p = 0.67). Conclusion: Total PTX did not induce significant effect concerning postoperative hypocalcemia, operative complications and use of long-term calcium and vitamin D supplement. Previous reports had shown that partial PTX may lead to more recurrence of hyperparathyroidism, especially in patients without renal transplant. Our study showed that total PTX can be performed safely and could be considered as the surgical treatment of secondary hyperparathyroidism refractory to medical treatment. EFP2